Brett Finlay - Publications

University of British Columbia, Vancouver, Vancouver, BC, Canada 
Cell Biology, Pathology

92 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 van der Heijden J, Reynolds LA, Deng W, Mills A, Scholz R, Imami K, Foster LJ, Duong F, Finlay BB. Salmonella Rapidly Regulates Membrane Permeability To Survive Oxidative Stress. Mbio. 7. PMID 27507830 DOI: 10.1128/mBio.01238-16  0.48
2016 Arrieta MC, Sadarangani M, Brown EM, Russell SL, Nimmo M, Dean J, Turvey SE, Chan ES, Finlay BB. A humanized microbiota mouse model of ovalbumin-induced lung inflammation. Gut Microbes. 0. PMID 27115049 DOI: 10.1080/19490976.2016.1182293  0.48
2016 Law RJ, Law HT, Scurll JM, Scholz R, Santos AS, Shames SR, Deng W, Croxen MA, Li Y, de Hoog CL, van der Heijden J, Foster LJ, Guttman JA, Finlay BB. Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors. Journal of Proteome Research. PMID 27018634 DOI: 10.1021/acs.jproteome.6b00074  0.48
2015 Yang JS, Kim HJ, Kang SS, Kim KW, Kim DW, Yun CH, Park SJ, Seo HS, Finlay BB, Han SH. TLR2, but not TLR4, plays a predominant role in the immune responses to cholera vaccines. Journal of Leukocyte Biology. PMID 26078314 DOI: 10.1189/jlb.4A1014-498R  0.48
2015 Vogt SL, Peña-Díaz J, Finlay BB. Chemical communication in the gut: Effects of microbiota-generated metabolites on gastrointestinal bacterial pathogens. Anaerobe. 34: 106-115. PMID 25958185 DOI: 10.1016/j.anaerobe.2015.05.002  0.48
2015 Scholz R, Imami K, Scott NE, Trimble WS, Foster LJ, Finlay BB. Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis. Molecular & Cellular Proteomics : McP. PMID 25944883 DOI: 10.1074/mcp.M114.046847  0.48
2015 Bhullar K, Zarepour M, Yu H, Yang H, Croxen M, Stahl M, Finlay BB, Turvey SE, Vallance BA. The serine protease autotransporter Pic modulates Citrobacter rodentium pathogenesis and its innate recognition by the host. Infection and Immunity. PMID 25895966 DOI: 10.1128/IAI.00025-15  0.48
2015 Burkinshaw BJ, Deng W, Lameignère E, Wasney GA, Zhu H, Worrall LJ, Finlay BB, Strynadka NC. Structural analysis of a specialized type III secretion system peptidoglycan-cleaving enzyme. The Journal of Biological Chemistry. 290: 10406-17. PMID 25678709 DOI: 10.1074/jbc.M115.639013  0.48
2015 Caballero-Flores GG, Croxen MA, Martínez-Santos VI, Finlay BB, Puente JL. Identification and regulation of a novel Citrobacter rodentium gut colonization fimbria (Gcf). Journal of Bacteriology. 197: 1478-91. PMID 25666139 DOI: 10.1128/JB.02486-14  0.52
2015 Waldor MK, Tyson G, Borenstein E, Ochman H, Moeller A, Finlay BB, Kong HH, Gordon JI, Nelson KE, Dabbagh K, Smith H. Where next for microbiome research? Plos Biology. 13: e1002050. PMID 25602283 DOI: 10.1371/journal.pbio.1002050  0.48
2015 Santos AS, Finlay BB. Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways. Cellular Microbiology. 17: 318-32. PMID 25588886 DOI: 10.1111/cmi.12412  0.48
2015 Russell SL, Gold MJ, Reynolds LA, Willing BP, Dimitriu P, Thorson L, Redpath SA, Perona-Wright G, Blanchet MR, Mohn WW, Finlay BB, McNagny KM. Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. The Journal of Allergy and Clinical Immunology. 135: 100-9. PMID 25145536 DOI: 10.1016/j.jaci.2014.06.027  0.48
2014 Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB, Harder KW. Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. Journal of Immunology (Baltimore, Md. : 1950). 193: 5249-63. PMID 25339668 DOI: 10.4049/jimmunol.1302832  0.48
2014 Yurist-Doutsch S, Arrieta MC, Vogt SL, Finlay BB. Gastrointestinal microbiota-mediated control of enteric pathogens. Annual Review of Genetics. 48: 361-82. PMID 25251855 DOI: 10.1146/annurev-genet-120213-092421  0.48
2014 Reynolds LA, Smith KA, Filbey KJ, Harcus Y, Hewitson JP, Redpath SA, Valdez Y, Yebra MJ, Finlay BB, Maizels RM. Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes. 5: 522-32. PMID 25144609 DOI: 10.4161/gmic.32155  0.48
2014 Valdez Y, Brown EM, Finlay BB. Influence of the microbiota on vaccine effectiveness. Trends in Immunology. 35: 526-37. PMID 25113637 DOI: 10.1016/  0.48
2014 Collins JW, Keeney KM, Crepin VF, Rathinam VA, Fitzgerald KA, Finlay BB, Frankel G. Citrobacter rodentium: infection, inflammation and the microbiota. Nature Reviews. Microbiology. 12: 612-23. PMID 25088150 DOI: 10.1038/nrmicro3315  0.48
2014 Antunes LC, McDonald JA, Schroeter K, Carlucci C, Ferreira RB, Wang M, Yurist-Doutsch S, Hira G, Jacobson K, Davies J, Allen-Vercoe E, Finlay BB. Antivirulence activity of the human gut metabolome. Mbio. 5: e01183-14. PMID 25073640 DOI: 10.1128/mBio.01183-14  0.48
2014 Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB. Effects of antibiotics on human microbiota and subsequent disease. Annual Review of Microbiology. 68: 217-35. PMID 24995874 DOI: 10.1146/annurev-micro-091313-103456  0.48
2014 Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 156: 1045-59. PMID 24581500 DOI: 10.1016/j.cell.2014.01.026  0.48
2014 Kumar NS, Dullaghan EM, Finlay BB, Gong H, Reiner NE, Jon Paul Selvam J, Thorson LM, Campbell S, Vitko N, Richardson AR, Zoraghi R, Young RN. Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections. Bioorganic & Medicinal Chemistry. 22: 1708-25. PMID 24508307 DOI: 10.1016/j.bmc.2014.01.020  0.48
2013 Brown EM, Arrieta MC, Finlay BB. A fresh look at the hygiene hypothesis: how intestinal microbial exposure drives immune effector responses in atopic disease. Seminars in Immunology. 25: 378-87. PMID 24209708 DOI: 10.1016/j.smim.2013.09.003  0.48
2013 Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clinical Microbiology Reviews. 26: 822-80. PMID 24092857 DOI: 10.1128/CMR.00022-13  0.48
2013 Marchiando AM, Ramanan D, Ding Y, Gomez LE, Hubbard-Lucey VM, Maurer K, Wang C, Ziel JW, van Rooijen N, Nuñez G, Finlay BB, Mysorekar IU, Cadwell K. A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host & Microbe. 14: 216-24. PMID 23954160 DOI: 10.1016/j.chom.2013.07.013  0.48
2013 Bhavsar AP, Brown NF, Stoepel J, Wiermer M, Martin DD, Hsu KJ, Imami K, Ross CJ, Hayden MR, Foster LJ, Li X, Hieter P, Finlay BB. The Salmonella type III effector SspH2 specifically exploits the NLR co-chaperone activity of SGT1 to subvert immunity. Plos Pathogens. 9: e1003518. PMID 23935490 DOI: 10.1371/journal.ppat.1003518  0.48
2013 Buckner MM, Antunes LC, Gill N, Russell SL, Shames SR, Finlay BB. 15-Deoxy-Δ12,14-prostaglandin J2 inhibits macrophage colonization by Salmonella enterica serovar Typhimurium. Plos One. 8: e69759. PMID 23922794 DOI: 10.1371/journal.pone.0069759  0.48
2013 Donnenberg MS, Finlay BB. Combating enteropathogenic Escherichia coli (EPEC) infections: the way forward. Trends in Microbiology. 21: 317-9. PMID 23815982 DOI: 10.1016/j.tim.2013.05.003  0.48
2013 Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine Nature Immunology. 14: 660-667. PMID 23778793 DOI: 10.1038/ni.2611  0.48
2013 Sal-Man N, Setiaputra D, Scholz R, Deng W, Yu AC, Strynadka NC, Finlay BB. EscE and EscG are cochaperones for the type III needle protein EscF of enteropathogenic Escherichia coli. Journal of Bacteriology. 195: 2481-9. PMID 23524615 DOI: 10.1128/JB.00118-13  0.48
2013 Imami K, Bhavsar AP, Yu H, Brown NF, Rogers LD, Finlay BB, Foster LJ. Global impact of Salmonella pathogenicity island 2-secreted effectors on the host phosphoproteome. Molecular & Cellular Proteomics : McP. 12: 1632-43. PMID 23459991 DOI: 10.1074/mcp.M112.026161  0.48
2013 Olsen RL, Echtenkamp F, Cheranova D, Deng W, Finlay BB, Hardwidge PR. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21. Veterinary Microbiology. 164: 164-70. PMID 23434013 DOI: 10.1016/j.vetmic.2013.01.028  0.48
2013 Keeney KM, Finlay BB. Microbiology: EHEC downregulates virulence in response to intestinal fucose. Current Biology : Cb. 23: R108-10. PMID 23391383 DOI: 10.1016/j.cub.2012.12.027  0.48
2013 Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes. 4: 158-64. PMID 23333861 DOI: 10.4161/gmic.23567  0.48
2013 Kindrachuk J, Jenssen H, Elliott M, Nijnik A, Magrangeas-Janot L, Pasupuleti M, Thorson L, Ma S, Easton DM, Bains M, Finlay B, Breukink EJ, Georg-Sahl H, Hancock RE. Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory. Innate Immunity. 19: 315-27. PMID 23109507 DOI: 10.1177/1753425912461456  0.48
2012 Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V, Finlay BB. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host & Microbe. 12: 611-22. PMID 23159051 DOI: 10.1016/j.chom.2012.10.012  0.48
2012 Russell SL, Finlay BB. The impact of gut microbes in allergic diseases. Current Opinion in Gastroenterology. 28: 563-9. PMID 23010680 DOI: 10.1097/MOG.0b013e3283573017  0.48
2012 Prehna G, Li Y, Stoynov N, Okon M, Vuckovic M, McIntosh LP, Foster LJ, Finlay BB, Strynadka NC. The zinc regulated antivirulence pathway of Salmonella is a multiprotein immunoglobulin adhesion system. The Journal of Biological Chemistry. 287: 32324-37. PMID 22810234 DOI: 10.1074/jbc.M112.357210  0.48
2012 Deng W, Yu HB, de Hoog CL, Stoynov N, Li Y, Foster LJ, Finlay BB. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens. Molecular & Cellular Proteomics : McP. 11: 692-709. PMID 22661456 DOI: 10.1074/mcp.M111.013672  0.48
2012 Achtman AH, Pilat S, Law CW, Lynn DJ, Janot L, Mayer ML, Ma S, Kindrachuk J, Finlay BB, Brinkman FS, Smyth GK, Hancock RE, Schofield L. Effective adjunctive therapy by an innate defense regulatory peptide in a preclinical model of severe malaria. Science Translational Medicine. 4: 135ra64. PMID 22623740 DOI: 10.1126/scitranslmed.3003515  0.48
2012 Sal-Man N, Biemans-Oldehinkel E, Sharon D, Croxen MA, Scholz R, Foster LJ, Finlay BB. EscA is a crucial component of the type III secretion system of enteropathogenic Escherichia coli. Journal of Bacteriology. 194: 2819-28. PMID 22447907 DOI: 10.1128/JB.00103-12  0.48
2012 Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M, Gill N, Blanchet MR, Mohn WW, McNagny KM, Finlay BB. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. Embo Reports. 13: 440-7. PMID 22422004 DOI: 10.1038/embor.2012.32  0.48
2012 Antunes LC, Wang M, Andersen SK, Ferreira RB, Kappelhoff R, Han J, Borchers CH, Finlay BB. Repression of Salmonella enterica phoP expression by small molecules from physiological bile. Journal of Bacteriology. 194: 2286-96. PMID 22366421 DOI: 10.1128/JB.00104-12  0.48
2012 Axerio-Cilies P, See RH, Zoraghi R, Worral L, Lian T, Stoynov N, Jiang J, Kaur S, Jackson L, Gong H, Swayze R, Amandoron E, Kumar NS, Moreau A, Hsing M, ... ... Finlay BB, et al. Cheminformatics-driven discovery of selective, nanomolar inhibitors for staphylococcal pyruvate kinase. Acs Chemical Biology. 7: 350-9. PMID 22066782 DOI: 10.1021/cb2003576  0.48
2012 Auweter SD, Yu HB, Arena ET, Guttman JA, Finlay BB. Oxysterol-binding protein (OSBP) enhances replication of intracellular Salmonella and binds the Salmonella SPI-2 effector SseL via its N-terminus. Microbes and Infection / Institut Pasteur. 14: 148-54. PMID 21988961 DOI: 10.1016/j.micinf.2011.09.003  0.48
2011 Zoraghi R, Worrall L, See RH, Strangman W, Popplewell WL, Gong H, Samaai T, Swayze RD, Kaur S, Vuckovic M, Finlay BB, Brunham RC, McMaster WR, Davies-Coleman MT, Strynadka NC, et al. Methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as a target for bis-indole alkaloids with antibacterial activities. The Journal of Biological Chemistry. 286: 44716-25. PMID 22030393 DOI: 10.1074/jbc.M111.289033  0.48
2011 Arena ET, Auweter SD, Antunes LC, Vogl AW, Han J, Guttman JA, Croxen MA, Menendez A, Covey SD, Borchers CH, Finlay BB. The deubiquitinase activity of the Salmonella pathogenicity island 2 effector, SseL, prevents accumulation of cellular lipid droplets. Infection and Immunity. 79: 4392-400. PMID 21875964 DOI: 10.1128/IAI.05478-11  0.48
2011 Shames SR, Bhavsar AP, Croxen MA, Law RJ, Mak SH, Deng W, Li Y, Bidshari R, de Hoog CL, Foster LJ, Finlay BB. The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cellular Microbiology. 13: 1542-57. PMID 21812888 DOI: 10.1111/j.1462-5822.2011.01640.x  0.48
2011 Biemans-Oldehinkel E, Sal-Man N, Deng W, Foster LJ, Finlay BB. Quantitative proteomic analysis reveals formation of an EscL-EscQ-EscN type III complex in enteropathogenic Escherichia coli. Journal of Bacteriology. 193: 5514-9. PMID 21804003 DOI: 10.1128/JB.05235-11  0.48
2011 Antunes LC, Andersen SK, Menendez A, Arena ET, Han J, Ferreira RB, Borchers CH, Finlay BB. Metabolomics reveals phospholipids as important nutrient sources during Salmonella growth in bile in vitro and in vivo. Journal of Bacteriology. 193: 4719-25. PMID 21764918 DOI: 10.1128/JB.05132-11  0.48
2011 Sham HP, Shames SR, Croxen MA, Ma C, Chan JM, Khan MA, Wickham ME, Deng W, Finlay BB, Vallance BA. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. Infection and Immunity. 79: 3552-62. PMID 21746856 DOI: 10.1128/IAI.05033-11  0.48
2011 Ferreira RB, Gill N, Willing BP, Antunes LC, Russell SL, Croxen MA, Finlay BB. The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. Plos One. 6: e20338. PMID 21633507 DOI: 10.1371/journal.pone.0020338  0.48
2008 Valdez Y, Diehl GE, Vallance BA, Grassl GA, Guttman JA, Brown NF, Rosenberger CM, Littman DR, Gros P, Finlay BB. Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection. Cellular Microbiology. 10: 1646-61. PMID 18397382 DOI: 10.1111/j.1462-5822.2008.01155.x  0.48
2006 Goosney DL, Kujat Choy SL, Finlay BB. Salmonella and Enteropathogenic Escherichia coli Interactions with Host Cells: Signaling Pathways. Ecosal Plus. 2. PMID 26443572 DOI: 10.1128/ecosalplus.8.8.4  0.72
2006 Khan MA, Ma C, Knodler LA, Valdez Y, Rosenberger CM, Deng W, Finlay BB, Vallance BA. Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice. Infection and Immunity. 74: 2522-36. PMID 16622187 DOI: 10.1128/IAI.74.5.2522-2536.2006  0.68
2006 Linington RG, Robertson M, Gauthier A, Finlay BB, MacMillan JB, Molinski TF, van Soest R, Andersen RJ. Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia. Journal of Natural Products. 69: 173-7. PMID 16499312 DOI: 10.1021/np050192h  0.48
2006 Martin-Orozco N, Touret N, Zaharik ML, Park E, Kopelman R, Miller S, Finlay BB, Gros P, Grinstein S. Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. Molecular Biology of the Cell. 17: 498-510. PMID 16251362 DOI: 10.1091/mbc.E04-12-1096  0.48
2005 Gauthier A, Robertson ML, Lowden M, Ibarra JA, Puente JL, Finlay BB. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrobial Agents and Chemotherapy. 49: 4101-9. PMID 16189086 DOI: 10.1128/AAC.49.10.4101-4109.2005  0.48
2004 Zaharik ML, Cullen VL, Fung AM, Libby SJ, Kujat Choy SL, Coburn B, Kehres DG, Maguire ME, Fang FC, Finlay BB. The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infection and Immunity. 72: 5522-5. PMID 15322058 DOI: 10.1128/IAI.72.9.5522-5525.2004  0.48
2004 Pollard AJ, Currie A, Rosenberger CM, Heale JP, Finlay BB, Speert DP. Differential post-transcriptional activation of human phagocytes by different Pseudomonas aeruginosa isolates. Cellular Microbiology. 6: 639-50. PMID 15186400 DOI: 10.1111/j.1462-5822.2004.00388.x  0.48
2004 Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proceedings of the National Academy of Sciences of the United States of America. 101: 2422-7. PMID 14983025  0.68
2004 Zaharik ML, Finlay BB. Mn2+ and bacterial pathogenesis. Frontiers in Bioscience : a Journal and Virtual Library. 9: 1035-42. PMID 14977526  0.92
2003 Gauthier A, Finlay BB. Translocated intimin receptor and its chaperone interact with ATPase of the type III secretion apparatus of enteropathogenic Escherichia coli. Journal of Bacteriology. 185: 6747-55. PMID 14617638  0.96
2003 Gauthier A, Puente JL, Finlay BB. Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization. Infection and Immunity. 71: 3310-9. PMID 12761113  0.96
2003 Gauthier A, Thomas NA, Finlay BB. Bacterial injection machines. The Journal of Biological Chemistry. 278: 25273-6. PMID 12759358 DOI: 10.1074/jbc.R300012200  0.96
2003 Rosenberger CM, Finlay BB. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nature Reviews. Molecular Cell Biology. 4: 385-96. PMID 12728272 DOI: 10.1038/nrm1104  0.68
2002 Zaharik ML, Vallance BA, Puente JL, Gros P, Finlay BB. Host-pathogen interactions: Host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-2 virulence genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 15705-10. PMID 12441401 DOI: 10.1073/pnas.252415599  0.92
2002 Linington RG, Robertson M, Gauthier A, Finlay BB, van Soest R, Andersen RJ. Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia. Organic Letters. 4: 4089-92. PMID 12423093 DOI: 10.1021/ol0268337  0.48
2002 Brumell JH, Tang P, Zaharik ML, Finlay BB. Disruption of the Salmonella-containing vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the cytosol of epithelial cells. Infection and Immunity. 70: 3264-70. PMID 12011022 DOI: 10.1128/IAI.70.6.3264-3270.2002  0.48
2002 Brumell JH, Goosney DL, Finlay BB. SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic (Copenhagen, Denmark). 3: 407-15. PMID 12010459 DOI: 10.1034/j.1600-0854.2002.30604.x  0.48
2002 Zaharik ML, Gruenheid S, Perrin AJ, Finlay BB. Delivery of dangerous goods: type III secretion in enteric pathogens. International Journal of Medical Microbiology : Ijmm. 291: 593-603. PMID 12008913 DOI: 10.1078/1438-4221-00179  0.48
2002 Rosenberger CM, Finlay BB. Macrophages inhibit Salmonella typhimurium replication through MEK/ERK kinase and phagocyte NADPH oxidase activities. The Journal of Biological Chemistry. 277: 18753-62. PMID 11821396 DOI: 10.1074/jbc.M110649200  0.68
2002 Brumell JH, Perrin AJ, Goosney DL, Finlay BB. Microbial pathogenesis: New niches for Salmonella Current Biology. 12: R15-R17. PMID 11790317 DOI: 10.1016/S0960-9822(01)00640-6  0.48
2001 Rosenberger CM, Pollard AJ, Finlay BB. Gene array technology to determine host responses to Salmonella. Microbes and Infection / Institut Pasteur. 3: 1353-60. PMID 11755425  0.68
2001 DeVinney R, Puente JL, Gauthier A, Goosney D, Finlay BB. Enterohaemorrhagic and enteropathogenic Escherichia coli use a different Tir-based mechanism for pedestal formation. Molecular Microbiology. 41: 1445-58. PMID 11580847  0.96
2001 de Grado M, Rosenberger CM, Gauthier A, Vallance BA, Finlay BB. Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells. Infection and Immunity. 69: 6217-24. PMID 11553563 DOI: 10.1128/IAI.69.10.6217-6224.2001  0.96
2001 Gauthier A, Finlay BB. Bacterial pathogenesis: the answer to virulence is in the pore. Current Biology : Cb. 11: R264-7. PMID 11413015  0.96
2001 Goosney DL, DeVinney R, Finlay BB. Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals. Infection and Immunity. 69: 3315-22. PMID 11292754 DOI: 10.1128/IAI.69.5.3315-3322.2001  0.72
2001 Brumell JH, Rosenberger CM, Gotto GT, Marcus SL, Finlay BB. SifA permits survival and replication of Salmonella typhimurium in murine macrophages. Cellular Microbiology. 3: 75-84. PMID 11207622 DOI: 10.1046/j.1462-5822.2001.00087.x  0.48
2000 Rosenberger CM, Brumell JH, Finlay BB. Microbial pathogenesis: lipid rafts as pathogen portals. Current Biology : Cb. 10: R823-5. PMID 11102822 DOI: 10.1016/S0960-9822(00)00788-0  0.48
2000 Goosney DL, Gruenheid S, Finlay BB. Gut feelings: Enteropathogenic E. coli (EPEC) interactions with the host Annual Review of Cell and Developmental Biology. 16: 173-189. PMID 11031234 DOI: 10.1146/annurev.cellbio.16.1.173  0.48
2000 Scott MG, Rosenberger CM, Gold MR, Finlay BB, Hancock RE. An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. Journal of Immunology (Baltimore, Md. : 1950). 165: 3358-65. PMID 10975854  0.68
2000 Goosney DL, DeVinney R, Pfuetzner RA, Frey EA, Strynadka NC, Finlay BB. Enteropathogenic E. coli translocated intimin receptor, Tir, interacts directly with alpha-actinin. Current Biology : Cb. 10: 735-8. PMID 10873808  0.72
2000 Gauthier A, de Grado M, Finlay BB. Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes. Infection and Immunity. 68: 4344-8. PMID 10858257  0.96
2000 Kehres DG, Zaharik ML, Finlay BB, Maguire ME. The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Molecular Microbiology. 36: 1085-100. PMID 10844693  0.92
2000 Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. Journal of Immunology (Baltimore, Md. : 1950). 164: 5894-904. PMID 10820271  0.68
1999 de Grado M, Abe A, Gauthier A, Steele-Mortimer O, DeVinney R, Finlay BB. Identification of the intimin-binding domain of Tir of enteropathogenic Escherichia coli. Cellular Microbiology. 1: 7-17. PMID 11207537  0.96
1999 Kalman D, Weiner OD, Goosney DL, Sedat JW, Finlay BB, Abo A, Bishop JM. Enteropathogenic E. coli acts through WASP and Arp2/3 complex to form actin pedestals. Nature Cell Biology. 1: 389-91. PMID 10559969 DOI: 10.1038/14087  0.48
1999 DeVinney R, Gauthier A, Abe A, Finlay BB. Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells. Cellular and Molecular Life Sciences : Cmls. 55: 961-76. PMID 10412374  0.96
1999 Goosney DL, Knoechel DG, Finlay BB. Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. Emerging Infectious Diseases. 5: 216-23. PMID 10221873 DOI: 10.3201/eid0502.990205  0.72
1999 Goosney DL, de Grado M, Finlay BB. Putting E. coli on a pedestal: a unique system to study signal transduction and the actin cytoskeleton. Trends in Cell Biology. 9: 11-4. PMID 10087611  0.72
1999 Goosney DL, Celli J, Kenny B, Finlay BB. Enteropathogenic Escherichia coli inhibits phagocytosis. Infection and Immunity. 67: 490-5. PMID 9916050  0.72
1998 Gauthier A, Finlay BB. Protein translocation: delivering virulence into the host cell. Current Biology : Cb. 8: R768-70. PMID 9799724  0.96
Show low-probability matches.